NEW YORK (GenomeWeb News) — Johnson & Johnson Pharmaceutical Research and Development is expanding its facilities in Spring House, Pa., that will house drug-development research into biomarkers, structural biology, and pharmacogenomics, the company said yesterday.
The new facility, expected to be completed in 2009, will add around 150,000 square feet to the Spring House complex. The company said it plans to keep the 680 employees on the campus, and said it expects to hire 120 more.